Emergent BioSolutions Inc. — Director's Dealing 2020

Sep 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2020-09-02

Reporting Person: SULLIVAN LOUIS W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-02	Common Stock	S	20525	$111.2157	Disposed	42762	Direct
2020-09-02	Common Stock	M	7893	$20.08	Acquired	50655	Direct
2020-09-02	Common Stock	S	7893	$111.2256	Disposed	42762	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-02	Employee Stock Options (Right to Buy)	$20.08	M	7893	Acquired	2021-05-19	Common Stock (7893.0)	Direct

Footnotes

F1: Consists of previously exercised options granted under the company's stock incentive plan as amended and restated.

F2: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices between $110.96 and $111.40.

F3: Consists of an option granted under the company's stock incentive plan as amended and restated.

F4: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices between $110.96 and $111.32.

F5: The option grant is fully vested.